188 related articles for article (PubMed ID: 6146650)
1. Genetically determined resistance to mouse hepatitis virus 3 is expressed in hematopoietic donor cells in radiation chimeras.
Dupuy JM; Dupuy C; Décarie D
J Immunol; 1984 Sep; 133(3):1609-13. PubMed ID: 6146650
[TBL] [Abstract][Full Text] [Related]
2. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
Miller SC
J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
[TBL] [Abstract][Full Text] [Related]
3. Neonatal susceptibility to MHV3 infection in mice. I. Transfer of resistance.
Levy-Leblond E; Dupuy JM
J Immunol; 1977 Apr; 118(4):1219-22. PubMed ID: 300403
[TBL] [Abstract][Full Text] [Related]
4. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
Lamontagne L; Descoteaux JP; Jolicoeur P
J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
[TBL] [Abstract][Full Text] [Related]
5. Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance.
Tardieu M; Héry C; Dupuy JM
J Immunol; 1980 Jan; 124(1):418-23. PubMed ID: 6243152
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine release as measurement of anti-mouse hepatitis virus type 3 (MHV3) cellular reactions in various mouse lines exhibiting differential susceptibilities to MHV3-induced paralysis.
Mansour S; Mercier G; Oth D
Acta Virol; 1990 Sep; 34(5):423-32. PubMed ID: 1981453
[TBL] [Abstract][Full Text] [Related]
7. Efficient natural defense mechanisms against Listeria monocytogenes in T and B cell-deficient allogeneic bone marrow radiation chimeras. Preactivated macrophages are the main effector cells in an early phase after bone marrow transfer.
Roesler J; Gröttrup E; Baccarini M; Lohmann-Mattes ML
J Immunol; 1989 Sep; 143(5):1710-5. PubMed ID: 2668412
[TBL] [Abstract][Full Text] [Related]
8. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations.
Jolicoeur P; Lamontagne L
J Immunol; 1989 Dec; 143(11):3722-30. PubMed ID: 2555417
[TBL] [Abstract][Full Text] [Related]
9. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3.
Jolicoeur P; Lamontagne L
J Immunol; 1994 Aug; 153(3):1318-7. PubMed ID: 8027559
[TBL] [Abstract][Full Text] [Related]
10. Anti-bacterial immunity to Listeria monocytogenes in allogeneic bone marrow chimera in mice.
Onoé K; Good RA; Yamamoto K
J Immunol; 1986 Jun; 136(11):4264-9. PubMed ID: 2871109
[TBL] [Abstract][Full Text] [Related]
11. Genetic study of mouse sensitivity to MHV3 infection: influence of the H-2 complex.
Lévy-Leblond E; Oth D; Dupuy JM
J Immunol; 1979 Apr; 122(4):1359-62. PubMed ID: 448093
[TBL] [Abstract][Full Text] [Related]
12. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
13. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
14. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.
Le Prevost C; Levy-Leblond E; Virelizier JL; Dupuy JM
J Immunol; 1975 Jan; 114(1 Pt 1):221-5. PubMed ID: 163277
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow cell-dependency of delayed-type hypersensitivity response in mice infected with mouse hepatitis virus.
Kyuwa S; Yamaguchi K; Fujiwara K; Yamanouchi K
Jpn J Exp Med; 1986 Jun; 56(3):93-8. PubMed ID: 3020283
[TBL] [Abstract][Full Text] [Related]
16. Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras.
Van Zant G; Scott-Micus K; Thompson BP; Fleischman RA; Perkins S
Exp Hematol; 1992 May; 20(4):470-5. PubMed ID: 1568464
[TBL] [Abstract][Full Text] [Related]
17. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
Norin AJ; Emeson EE; Veith FJ
J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
[TBL] [Abstract][Full Text] [Related]
20. Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection.
Prévost CL; Virelizier JL; Dupuy JM
J Immunol; 1975 Sep; 115(3):640-3. PubMed ID: 168262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
